Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

AVITA MEDICAL LTD

INVESTOR PRESENTATION - AVITA MEDICAL LTD

ASX:AVH

AVITA MEDICAL LTD

Health Care

Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. The company's products includes regenerative medicine products (ReCell Autologous Spray-On-Skin), ReGenercell and Renovacell.

Read more

Market Cap

$388.44m

Price at Close

$5.83

4w avg. Volume

799.61k

4w avg. Turnover

$4.83m

Announcements
announcementt+2 movementdate
  • Appendix 3G

    Issued Capital

  • -

    02 Dec 2020

-

02 Dec 2020
  • Cleansing Notice

    Issued Capital

  • -

    02 Dec 2020

-

02 Dec 2020
  • Cancellation of Stock Options/Restricted Stock Units

    Issued Capital

  • -

    02 Dec 2020

-

02 Dec 2020
  • AVH Appoints Kathy McGee as Chief Operating Officer

    Company Administration

  • +0.34%

    30 Nov 2020

+0.34%

30 Nov 2020
  • Corporate Presentation - November 2020

    Periodic Reports

  • -0.84%

    11 Nov 2020

-0.84%

11 Nov 2020
  • AVITA Reports Results for Three Months to 30 September 2020

    Periodic Reports · Market sensitive

  • -1.97%

    10 Nov 2020

-1.97%

10 Nov 2020
  • Final Director's Interest Notice - Damien McDonald

    Shareholder Details

  • -1.97%

    10 Nov 2020

-1.97%

10 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • -1.97%

    10 Nov 2020

-1.97%

10 Nov 2020
  • AVITA Therapeutics & Houston Methodist Enter Collaboration

    Progress Report

  • -3.86%

    08 Nov 2020

-3.86%

08 Nov 2020
  • AVITA Therapeutics, Inc. Announces Executive Change

    Company Administration

  • +2.69%

    06 Nov 2020

+2.69%

06 Nov 2020
Market Data

Current Price

$5.83

52WK HIGH

$9.11

52WK LOW

$0.325

1YR RETURN

+913.91%

1YR RETURN VS. SECTOR

+896.85%

90 DAY RETURN

-19.03%

ASX RANK

445

/2,030

SECTOR RANK

10

/47

SHARES OUTSTANDING

66.63m
ASX:AVH

AVITA MEDICAL LTD

Health Care

Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. The company's products includes regenerative medicine products (ReCell Autologous Spray-On-Skin), ReGenercell and Renovacell.

Read more

Market Cap

$388.44m

Price at Close

$5.83

4w avg. Volume

799.61k

4w avg. Turnover

$4.83m

ASX:AVH is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.